| NEWSLETTER:
MEMOTEXT NOTES |
Please
select an issue.
|
 |
Volume
1 | Issue
One
Organon Canada and MEMOTEXT launch the RemindMeToday.ca
program targeted at users of the Linessa and NuvaRing contraceptive
brands. |
|
Volume
1 | Issue
Two
As part of its expanded personalized adherence solution,
MEMOTEXT announces the release of MemotextPRO, a telephone-based
Patient Reported Outcomes (PRO) initiative. MemotextPRO
uses Speech-to-Text technology with professional transcription
validation. RemindMeToday.ca medication adherence program
achieves 91% retention. |
|
Volume
1 | Issue
Three
In a recent discussion with Meena Bhogal, Sr. Product
Manager, Contraceptive Portfolio, Organon Canada Ltd.,
Schering Plough, we asked how the RemindMeToday program
is doing and whether MEMOTEXT has delivered on its promises.
|
|
Volume
2 | Issue
Four
Telephone-Linked Care Highly Effective at Modifying Health
Behavior: Journal of Medical Systems Summary |
|
Volume
2 | Issue
Five
There is no Pill for Non-Adherence: Though dangerously wide
in scope and scale, medication non-compliance issues do
not yet appear to be top priority for health organizations
and stakeholders. |
|
Volume
3 | Issue
One
Synapse Group of USA and Canada provides scientific communications
and strategic direction to MEMOTEXT moving towards higher
standards of excellence in interactive health communications.
|
|
Volume
3 | Issue
Two
MEMOTEXT & Biogen Idec Canada Announce Ground-Breaking
Partnership to help patients with Multiple Sclerosis. |
